“The significance of the unequivocal identification of progesterone cannot be overstated,” the article by Guido F. Pauli and colleagues, states. “While the biological role of progesterone has been extensively studied in mammals, the reason for its presence in plants is less apparent.” They speculate that the hormone, like other steroid hormones, might be an ancient bioregulator that evolved billions of years ago, before the appearance of modern plants and animals. The new discovery may change scientific understanding of the evolution and function of progesterone in living things.
Scientists previously identified progesterone-like substances in plants and speculated that the hormone itself could exist in plants. But researchers had not found the actual hormone in plants until now. Pauli and colleagues used two powerful laboratory techniques, nuclear magnetic resonance and mass spectroscopy, to detect progesterone in leaves of the Common Walnut, or English Walnut, tree. They also identified five new progesterone-related steroids in a plant belonging to the buttercup family.
Two powerful laboratory techniques, nuclear magnetic resonance and mass spectroscopy were used by the researchers to detect progesterone in leaves of the Common Walnut, or English walnut, tree.
In the recent times, the spirit and fairness in baseball has been jolted by many times. Some of the biggest names in the world of baseball have been accused and confessed to use of steroids or other performance enhancing drugs.
One of the most impacting testimonials is the fact Manny Ramirez and David Ortiz were two of the players on baseball’s list of nearly 100 players who tested positive for banned substances in the year 2003, as per a report in THE TIMES.
The great Cal Ripken retired before steroid testing. After the disclosure about A-Rod’s failed test, Ripken announced that he wanted to have a talk with Rodriguez. Good for Ripken to step forward. But where was he when a loud and respected voice was needed to push the players union into testing?
Where does baseball go from here?
Hank Aaron has proposed a formula of putting asterisks on certain records to reflect the time in which they were accomplished. With all due respect to Aaron, every era seems to have had its legion of wrongdoers and shortcutters who used whatever science was available to get an edge. Amphetamines, red juice, concoctions and whatever else preceded steroids.
One thing is for sure, baseball fans hope that future doping disclosures do not name their favorite players. However, players need to stop admonishing news media and fans before that.
Patients suffering from Ulcerative Colitis (UV) can expect significant relief with hypnotherapy coming into the picture.
It was remarked by Keefer, who is director of the Center for Psychosocial Research in Intestinal Bowel Disease at Northwestern’s Feinberg School, that hypnotherapy may be effective for offering relief to these patients by helping them in stress management and developing a sense of control over their health.
“The preliminary results on the improved quality of life for the 27 subjects in this ongoing study (aiming for a total of 80 subjects) look positive so far,” Keefer said.
Once the eight weeks of hypnotherapy are completed, subjects are expected to listen to the relaxation tapes or practice relaxation twice a week to maintain the benefits. They are also encouraged to “step up their practice” of relaxation tapes if they think they are at risk for a flare, Keefer said.
Currently the treatment for the disease is a maintenance medication called 5-ASA. “The problem is most people forget to take the full dose,” Keefer said. If that doesn’t work steroids are often the next treatment, but long-term use can cause joint problems and other side effects such as anxiety and insomnia. When doctors try to taper the patient off steroids, symptoms tend to flare again.
The findings were presented by Keefer at the Crohn’s & Colitis Foundation of America’s 13th Annual Medical Symposium and 14th Annual Patient and Family Conference in Chicago.
Calcitriol, a form of vitamin D synthesized within the body, can possibly minimize growth-factor-induced HASM proliferation in cells in asthmatic as well as non-asthmatic people.
This finding was reported by researchers at the University of Pennsylvania who also noted that Vitamin D can slow down the progressive decline in breathing ability experienced in asthmatic patients due to human airway smooth muscle (HASM) proliferation.
With its anti-inflammatory qualities and its ability to inhibit smooth muscle proliferation, Dr. Damera said, calcitriol may become an important new therapy, used alone or in combination with already prescribed steroids, for treating steroid-resistant asthma.
Dr. Damera and his colleagues have also conducted experiments to determine the mechanism by which calcitriol retards HASM proliferation. They believe the vitamin works by inhibiting activation of distinct set of proteins responsible for cell-cycle progression.
The investigators have also conducted experiments to determine whether calcitriol, which is currently used to treat psoriasis, could be an effective therapy for COPD. Although preliminary, their data shows that calcitriol appears to reduce pro-inflammatory cytokine secretions in COPD. As with asthma, the researchers believe, calcitriol may also have the added benefit of slowing, if not stopping, the progression of airway remodeling. Others in the field believe calcitriol may also have the potential to inhibit the development and growth of several types of cancer.
A randomized control trial of calcitriol in patients with severe asthma with expectations of trial data in a year’s time is now being planned by the researchers as a part of the University of Pennsylvania’s Airway Biology Initiative.
Dietary supplements that are enriched with steroids pose a great risk for severe health ailments, a fact that was reaffirmed by three recent cases reported to researchers at the Henry Ford Hospital.
These cases have been discussed in detail in the current issue of The Journal of Clinical Gastroenterology and were related to patients with liver injury and renal failure.
The three cases outlined in the article now bring the total of cases reported in the last year to six.
“Anabolic steroids have long been known to cause liver damage, but what is not widely known is that over-the-counter health foodsupplements may actually contain these compounds,” says Dr. Gordon. “The buyer of these compounds likely has no idea that he is ingesting these agents, even after reading the small print on the label.”
The U.S. F.D.A. had already issued a warning in relation to over-the-counter sale of bodybuildingsupplements enriched with anabolic steroids.
It was remarked by lead author Stuart C. Gordon, M.D., Division of Gastroenterology and Hepatology at Henry Ford Hospital that though the numbers of such cases may be low now but that does not mean that such kind of supplements can be allowed to pose health risks.
Steroid tablets cannot be considered to be an effective form of treatment for offering relief to young children, especially pre-school children, suffering from wheezing induced by virus.
The finding was revealed by a research that involved medical experts at The University of Nottingham. Leading researchers from the universities of Nottingham, Leicester and Bart’s in London were at the center of a leading study to ascertain if steroids are useful for relieving symptoms of wheezing in children under the age of five.
There has been ongoing controversy in the medical community regarding how to best treat pre-school children who are admitted to hospital with severe wheezing. Steroids remain an important treatment for children with asthma but pre-school children with viral-induced wheeze, where symptoms are only associated with colds or flu and do not persist when the child is not infected with a virus, have also been treated with steroids in the past. This trial, funded by Asthma UK and published in the New England Journal of Medicine, definitively shows that steroidtablets do not help these children.
The research was carried out by Dr Alan Smyth, Associate Professor and Reader in Child Health, and Terence Stephenson, Professor of Child Health, at The University of Nottingham in collaboration with Dr Monica Lakhanpaul, Senior Lecturer from the University of Leicester and Consultant Paediatrician in Children’s Community Health Service for Leicester, Leicestershire and Rutland and Professor Jonathan Grigg of Barts and the London School of Medicine and Dentistry.
Dr Mike Thomas, Chief Medical Advisor for Asthma UK, welcoming the study remarked that the study results offer crucial implications for members of the medical community.
Professor Chris Haslett, Head of the Queen’s Medical Research Institute at the University of Edinburgh, expects the study to lead to trials of these drugs in human inflammatory diseases. Professors Adriano Rossi and Haslett, who have led this new study with other colleagues from the QMRI, said: “This study offers new hope for patients with severe inflammatory diseases. Specific treatment for such conditions is poor, and the use of steroids is fraught with potential difficulties. We have adopted a different strategy by using non-biological treatments, but this study needs urgently to be translated into trials and we are now seeking major funding to research further how these drugs work.”
Lab tests have suggested that some CDK inhibitors, like Roscovitine, can be effective treatment options for relieving pain and providing relief to patients with lung and joint diseases by reducing the inflammation level in models of rheumatoid arthritis and the fatal ailment called fibrosing alveolitis.
The game of baseball has been kept under dark clouds after Mark McGwire made a belated confession of steroid use amidst crocodile tears and disclaimers. But Bud Selig thinks that the baseball steroid era is now over, a fact suggested by test results.
Though McGwire’s confession was not able to impress the die-hard baseball fans, it saved officials and team members by putting an end to the baseball’s era of performance-enhancing drugs to offer a new start for the game.
That’s pretty much what Bud Selig said after the man who wouldn’t talk about the past to Congress finally spoke about it to Bob Costas. On the day of McGwire’s mea culpa, Selig said in a statement that in 2010, the use of steroids and amphetamines in baseball is “virtually nonexistent, as our testing results have shown.”
Two things: Either the commissioner of Major League Baseball pays no attention to the nonstop cat-and-mouse game still taking place between the International Olympic Committee and its world-class athletes, or he’s back to his old car-selling ways again.
If he ever really left them.
Otherwise, he would not have followed with this: “The so-called steroid era — a reference that is resented by the many players who played in that era and never touched the substances — is clearly a thing of the past, and Mark’s admission today is another step in the right direction.”
The steroid era might be a thing of the past in baseball. But performance-enhancing drugs are an ever-evolving industry, as the IOC and its testing agents long ago discovered. Simply stated, the cycle goes as follows: You design a testing program to detect all known performance-enhancing drugs. They design a new drug that escapes that detection. After a while, you get wise, develop even more encompassing detection. They take your test, and build a new PED that avoids that detection.
Selig remarked that the use of steroids and amphetamines is no more prevalent in the world of baseball.
The use of Avastin alone can be considered as an effective form of treatment when it comes to treating a subgroup of recurrent Grade 3 brain tumors in terms of delaying tumor progression, as per a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance.
Avastin, known generically as bevacizumab, is the first approved therapy designed for inhibiting angiogenesis that is a process in which new blood vessels develop and transport important nutrients to a tumor.
Chamberlain said he expects that patients treated with the drug will have a marked improvement in their quality of life because the use of steroids, a common treatment that has significant side effects, can be greatly reduced or even eliminated.
“While treatment with Avastin does dramatically improve survival time, the time that patients have left is of better quality and less about living with the disease itself,” Chamberlain said. In this study, the patients, ages 24-60, received an infusion of bevacizumab every two weeks for an average of 14.5 cycles (range was two to 39 cycles). Fourteen (64 percent) patients showed a partial response to the medicine as shown on radiographic scans. Two patients had stable disease and six had progressive disease. Progression-free survival ranged from three to 18 months and survival for the entire group of patients was three to 19 months.
Bevacizumab has the potential of being the best palliative treatment, as per Marc Chamberlain, M.D., author of this study that was published in the April 15 edition of the journal Cancer and director of the Neuro-oncology Program at the SCCA and a professor of neurology and neurological surgery at the University Of Washington School Of Medicine.
Individuals suffering from mild, persistent asthma and being administered with twice-daily use of inhaled steroids are likely to make lesser use of inhalers or find it easy to switch to a new pill.
It was remarked by Stephen P. Peters, M.D., Ph.D., lead author and a professor of pediatrics, internal medicine-pulmonary and associate director of the Center for Human Genomics, that this is good news for asthmatic patients because it offers them more choices in terms of asthma management.
The study, involving 500 children and adults with mild asthma, was conducted by the American Lung Association’s Asthma Clinical Research Centers. Its goal was to determine if patients whose symptoms are well controlled on twice daily inhaled corticosteroid can “step down” their medication use. The results are reported in the May 17 issue of the New England Journal of Medicine.
Asthma is considered mild, but persistent, when symptoms occur more than two times a week or cause the patient to awaken during the night more than twice a month. The standard treatment for mild-persistent asthma is twice-daily use of an inhaled steroid to prevent symptoms. Patients may also take additional drugs such as the inhaler albuterol, known as “rescue” therapy, to treat symptoms. A majority of people with asthma have mild disease, according to Peters.
The study involved patients whose asthma was treated with twice-daily inhaled fluticasone propionate (Flovent Discus), a commonly prescribed synthetic steroid. This drug is designed to suppress inflammation within the airways that can cause narrowing.
It was further remarked by Peters that asthmatic patients treated with twice a day inhaled corticosteroid doses and seeking other options must talk to their doctors before finalizing a decision.
In a finding seen by many as an overturn from conventional wisdom, a plant has been found to produce progesterone, the female sex hormone.
In the recent times, the spirit and fairness in baseball has been jolted by many times. Some of the biggest names in the world of baseball have been accused and confessed to use of 
Patients suffering from Ulcerative Colitis (UV) can expect significant relief with hypnotherapy coming into the picture.
Calcitriol, a form of vitamin D synthesized within the body, can possibly minimize growth-factor-induced HASM proliferation in cells in asthmatic as well as non-asthmatic people.
Dietary supplements that are enriched with 
Certain drugs that are presently used as treatment options for cancer can prove effective when it comes to minimizing the tissue inflammation level.
The game of baseball has been kept under dark clouds after Mark McGwire made a belated confession of 
The use of Avastin alone can be considered as an effective form of treatment when it comes to treating a subgroup of recurrent Grade 3 brain tumors in terms of delaying tumor progression, as per a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance.
Individuals suffering from mild, persistent asthma and being administered with twice-daily use of inhaled 